KOLs working with Iovance Biotherapeutics
10 key opinion leaders with clinical trial sponsorships or reported industry payments from Iovance Biotherapeutics. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.
Profiles
Corey Cutler, MD
Dana-Farber Cancer Institute
- 834
- publications
- 106
- h-index
- 13
- trials
Frederick Locke, MD
H. Lee Moffitt Cancer Center and Research Institute
- 863
- publications
- 62
- h-index
- 8
- trials
Richard Maziarz, MD
Oregon Health & Science University
- 720
- publications
- 86
- h-index
- 9
- trials
James Gulley, MD
National Cancer Institute
- 985
- publications
- 89
- h-index
- 28
- trials
Evan Lipson, MD
Johns Hopkins University
- 373
- publications
- 57
- h-index
- 6
- trials
Joel Neal, MD
Stanford University School of Medicine
- 601
- publications
- 56
- h-index
- 13
- trials
Brendan Curti, MD
Providence Cancer Institute
- 410
- publications
- 53
- h-index
- 17
- trials
Diwakar Davar, MBBS, MSc
UPMC Hillman Cancer Center
- 333
- publications
- 31
- h-index
- 17
- trials
Robert Figlin, MD
Cedars-Sinai Medical Center
- —
- publications
- 107
- h-index
- 8
- trials
Jared Weiss, MD
University of North Carolina at Chapel Hill
- —
- publications
- 32
- h-index
- 17
- trials
Filter, sort, and export all 10 working with Iovance Biotherapeutics in the directory